Director Yadin Rozov resigns from Oramed board for personal reasons

ORAMED PHARMACEUTICALS INC.

Yadin Rozov resigned from the Board of Directors effective January 17, 2024.
Resignation was for personal reasons; no disagreement with company operations, policies or practices.
No replacement or further board changes were announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Yadin Rozov

Director

ORMP · ORAMED PHARMACEUTICALS INC.

Effective: 2024-01-17
Filed: January 19, 2024, 6:59 PM ET

On January 17, 2024, Mr. Yadin Rozov, a member of the Board of Directors (the “Board”) of Oramed Pharmaceuticals Inc. (the “Company”), notified the Company of his intention to resign from the Board for personal reasons, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Yadin Rozov resigned as Director at ORAMED PHARMACEUTICALS INC..

Action: resigned
Role: Director

Exact text from the filing

On January 17, 2024, Mr. Yadin Rozov, a member of the Board of Directors (the “Board”) of Oramed Pharmaceuticals Inc. (the “Company”), notified the Company of his intention to resign from the Board for personal reasons, effective immediately.

View on SEC.gov

ORAMED PHARMACEUTICALS INC. filing history →

Source: SEC EDGAR

accession 0001213900-24-004905

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.